FairValu
ExxonMobil Holdings Corp

ExxonMobil Holdings Corp

XOMNYSE
Oil & Gas Integrated • Energycorporate.exxonmobil.com
Current Price
$165.990.00%
Market Cap
$682.54B
Shares Outstanding: 4.11B
Volume
-
Avg Vol (3M): -
Next Earnings
-
52 Week Range
Low: $--High: $--

Comprehensive AI Analysis

Strategic AI Analysis for XOM

Checking whether the approved providers contain enough current financial data for a reliable report.

Summary

Source-linked company research for XOM

Checking Factor Scorecard coverage

Financial statement coverage is being verified before factor scores are shown.

Price Chart

NYSE:XOM via TradingView

Loading TradingView chart...

Overview

Quarterly income statement data isn't available for this company.

No Data

No annual financial data available.

Financial Fundamentals

Growth, quality, valuation, cash generation, and balance-sheet strength.

Sector: Energy

Growth

TTM revenue plus current, long-term, forward, and accelerating top-line trends.

Revenue
-
Revenue Growth
-4.4%
Declining
Revenue CAGR 3Y
-
Forward Revenue Growth
22.5%
Strong
Revenue Acceleration
-6.9%
Slowing

Earnings

Trailing EPS, current EPS growth, long-term compounding, surprise, and forward expectations.

EPS (TTM)
6.11
Profitable
EPS Growth
-23.7%
Declining
EPS CAGR 3Y
-
EPS Surprise
13.3%
Strong Beat
Forward EPS
11.75
Profitable
Fwd Revenue Growth
22.5%
Forward EPS Growth
-8.1%
Declining

Profitability

TTM margin and return metrics that reflect pricing power and business quality.

Gross Margin
-
Operating Margin
-
Net Margin
7.6%
Positive
Margin vs Trend
-
ROE
10.0%
Good
ROIC
-

Cash Flow

TTM free cash flow, growth, margin, and operating-cash conversion quality.

Free Cash Flow
$18.79B
Positive
FCF Growth
-33.3%
Declining
FCF Margin
-
Cash Conversion
1.89x
Excellent

Valuation

Metrics ranked by issuer type, financial state, and input quality.

Cyclical businessPrimary lens

Forward P/E

Forward P/E is the best available lens because a positive EV/EBITDA multiple is unavailable.

Forward P/EPrimary
14.13x
High
EV / FCFSupporting
36.64x
High
Price / SalesContext
2.04x
Typical
Price / BookContext
2.68x
Typical

Financial Health

Latest-quarter liquidity and leverage checks plus TTM interest coverage.

Current Ratio
1.04x
Adequate
Quick Ratio
0.74x
Risky
Debt / Equity
0.06x
Conservative
Interest Coverage
-

Shareholder Signals

Capital returns and dilution checks sourced from statements and insider filings.

Dividend Yield
2.5%
Moderate
Payout Ratio
68.1%
High
Buyback Yield
3.0%
Positive
Net Insider Buys
-7
Selling

Peer Comparison

TickerPrice
XOMExxonMobil Holdings Corp
$165.99
Company Profile

About the Company

ExxonMobil Holdings Corporation engages in the exploration and production of crude oil and natural gas in the United States, Canada, and internationally. The company operates through Upstream, Energy Products, Chemical Products, and Specialty Products segments. Its Upstream segment explores for and produces crude oil and natural gas. The Energy Products segment offers fuels, aromatics, and catalysts, as well as licensing services. Its Chemical Products segment manufactures and sells olefins, polyolefins, and intermediates. The Specialty Products segment offers finished lubricants, basestocks, waxes, synthetics, elastomers, and resins. It is also involved in the manufacture, trade, transport, and sale of crude oil, natural gas, petroleum products, petrochemicals, and other specialty products; and pursuit of lower-emission and business opportunities, including carbon capture and storage, hydrogen, lower-emission fuels, Proxxima resin systems, carbon materials, low-carbon data center, and lithium. In addition, the company offers aviation fuel. It sells its products under the Exxon, Esso, and Mobil brands. The company was formerly known as Exxon Mobil Corporation and changed its name to ExxonMobil Holdings Corporation in July 2026. ExxonMobil Holdings Corporation was founded in 1870 and is headquartered in Spring, Texas.

Next Earnings Date

Oct 30, 2026

Loading latest news...

Revenue segmentation

Loading segment disclosures…